Biometals
Guntilleke S, Barrios AM, Arkin MR, Poole LB, Mckerrow
auranofin, a coordinated gold in vitro antitumor activity
and in vivo evaluation. Cancer Res 45:32–39
JH, Reed S (2012) A high throughput drug screen for
Entamoeba histolytica identifies a new lead and target. Nat
Med 18:956–960
Mirabelli CK, Johson RK, Hill DT, Faucette L, Girard GR, Kuo
GY, Sung CM, Crooke ST (1986) Correlation of the
in vitro cytotoxic and in vivo antitumor activities of
gold(I) coordination complexes. J Med Chem 29:218–223
Navarro M (2009) Gold complexes as potential anti-parasitic
agentes. Coord Chem Rev 253:1619–1626
Delaunay D, Toupet L, Le Corre M (1995) Reactivity of/b-
amino alcohols with carbon disulfide. Study on the syn-
thesis of 2-oxazolidinethiones and 2-thiazolidinethiones.
J Org Chem 60:6604–6607
Eisler R (2003) Chrysotherapy: a synoptic review. Inflamm Res
Ott I (2009) On the medicinal chemistry of gold complexes as
anticancer drugs. Coord Chem Rev 253:1670–1681
Ott I, Qian X, Xu Y, Vlecken DHW, Marques IJ, Kubutat D,
Sheldrick WS, Jesse P, Prokop A, Bagowski CP (2009) A
gold(I) phosphine complex containing a naphthalimide
ligand functions as a TrxR inhibiting antiproliferative
agent and angiogenesis inhibitor. J Med Chem 52:763–770
Rauter AP, Padilha M, Figueiredo JA, Ismael MI, Justino J,
Ferreira H, Ferreira MJ, Rajendran C, Wilkins R, Vaz PD,
Calhorda MJJ (2005) Bioactive pseudo-C-nucleosides
containing thiazole, theazolidinone, and tetrazole rings.
Carbohydr Chem 24:275–296
Reis RS, Ijr Neves, Louren c¸ o SLS, Fonseca LS, Louren c¸ o MCS
(2004) Comparison of flow cytometric and Alamar Blue
Tests with the proportional method for testing suscepti-
bility of Mycobacterium tuberculosis to rifampin and iso-
niazid. Clin Microbiol 42:2247–2248
Releling H, Rouville E, Chittenden GJF (1987) The chemistry of
D-gluconic acid derivatives. Part 1. Synthesis of 3,4;5,6-di-
O-isopropylidene-D-glucitol and 2,3;4,5-di-O-isopropyli-
dene-aldehydo-D-arabinose from D-glucono-1,5-lactone.
Rec Trav Chim Pays-Bas 106:461–464
Rigobello MP, Messori L, Marcon G, Bragadin M, Folda A,
Scutari G, Bindoli A (2004) Gold complexes inhibit
mitochondrial thioredoxin reductase: consequences on
mitochondrial functions. J Inorg Biochem 98:1634–1641
Sadler PJ, Nasr M, Narayanan VL (1984) In: Douple EB,
Krakhoff IH, Hacker MP (eds) Platinum coordination
complexes in cancer chemotherapy. Martinus Nijhoff
Publishers, Boston, pp 290–304
Shi J-C, Chen L-J, Huang S-Y, Wu D-X, Kang B-S (1997)
Chiral phosphine ligands derived from sugars 10. Synthe-
ses, structure, characterization and activity of the
gold(I) complexes with sugar-substructure phosphine
ligands. J Organomet Chem 535:17–23
Shoeib T, Atkinson DW, Sharp BL (2010) Structural analysis of
the anti-arthritic drug Auranofin: its complexes with cys-
teine, selenocysteine and their fragmentation products.
Inorg Chim Acta 363:184–192
Simon TM, Kunishima DH, Vibert GJ, Lorber A (1979) Inhi-
bitory effects of a new oral gold compound on hela cells.
Cancer 44:1965–1975
Simon TM, Kunishima DH, Vibert GJ, Lorber A (1981)
Screening trial with the coordinated gold compound aura-
nofin using mouse lymphocytic leukemia P3881. Cancer
Res 41:94–97
5
2:487–501
Eiter LC, Hall NW, Day CS, Saluta G, Kucera GL, Bierbach U
2009) Gold(I) analogues of a platinum-acridine antitumor
(
agent are only moderately cytotoxic bus show potent
activity against Mycobacterium tuberculosis. J Med Chem
5
2:6519–6522
Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G,
Hernandez A, Degnan MT, Cook MB, Quenzer VK, Fergu-
son RM, Gilman RH (1998) Rapid, low-technology MIC
determination with clinical Mycobacterium tuberculosis
isolates by using the microplate Alamar Blue Assay. J Clin
Microbiol 36:362–366
Gabbiani C, Casini A, Messori L (2007) Gold(III) compounds as
anticancer drugs. Gold Bull 40:73–81
Garegg PJ (1984) Some aspects of r e´ gio-stereo-, and chemos-
elective reactions in carbohydrate chemistry. Pure Appl
Chem 56:845–858
Gyepes A, Schaffer R, Bajor G, Woller A, Fodor P (2008) Syn-
thesis and chromatographic study of methyl-2,3-O-iso-
propylidene-5-dimethyl-arsinoyl-b-D-ribofuranoside and
methyl-2,3-O-isopropylidene-5-deoxy-5-dimethyl-thioarsi-
noyl-b-D-ribofuranoside. Polyhedron 27:2655–2661
Hickey JL, Ruhayel RA, Barnard PJ, Baker MV, Berners-Price
SJ, Filipovska
A
(2008) Mitochondria-targeted
chemotherapeutics: the rational design of gold(I) N-hete-
rocyclic carbene complexes that are selectively toxic to
cancer cells and target protein selenols in preference to
thiols. J Am Chem Soc 130:12570–12571
Ingles DL, Whistler RL (1962) Preparation of several methyl D-
pentothiapyranosides. J Org Chem 27:3896–3898
Lessa JA, Ferraz KSO, Guerra JC, De Miranda LF, Romeiro
CFD, Souza-Fagundes EM, Barbeira PJS, Beraldo H
(2012) Spectroscopic and electrochemical characterization
of gold(I) and gold(III) complexes with glyoxaldehyde
bis(thiosemicarbazones): cytotoxicity against human
tumor cell lines and inhibition of thioredoxin reductase
activity. Biometals 25:587–598
Maiore L, Cinellu MA, Nobili S, Landini I, Mini E, Gabbiani C,
Messori L (2012) Gold(III) complexes with 2-substituted
pyridines as experimental anticancer agents: solution
behavior, reactions with model proteins, antiproliferative
properties. J Inorg Biochem 108:123–127
Messori L, Marcon G (2004) Gold complexes as antitumor
agents. Met Ions Biol 42:385–424
Messori L, Francesco A, Marcon G, Orioli P, Fontani M, Mini E,
Mazzei T, Carott S, O’connell T, Zanello P (2000)
Gold(III) complexes as potential antitumor agents: solution
chemistry and cytotoxic properties of some selected
gold(III) compounds. J Med Chem 43:3541–3548
Sout EI, Doane WM, Russell CR, Jones LB (1975) Photolysis of
some carbohydrate dithiobis(thioformates). J Org Chem
40:1331–1336
Sun RW-Y, Che C-M (2009) The anti-cancer properties of
gold(III) compounds with dianionic porphyrin and
tetradentate ligands. Coord Chem Rev 253:1682–1691
Mirabelli CK, Johson RK, Sung CM, Faucette L, Muirhead K,
Crooke ST (1985) Models cytotoxic properties of
123